Top Markets
Coin of the day
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Star Lake Bioscience Co., Inc.Zhaoqing Guangdong

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong

600866
Pozycja w akcjach #9223
Established in 1964 and headquartered in Zhaoqing, China, Star Lake Bioscience... Established in 1964 and headquartered in Zhaoqing, China, Star Lake Bioscience Co., Inc. specializes in the production and global distribution of pharmaceutical ingredients, as well as food and animal feed additives. Its extensive product catalog includes guanosine, which serves as a crucial intermediate for both food and pharmaceutical applications. The company also manufactures L-proline, a vital intermediate for synthesizing captopril and enalapril, and a raw material used in amino acid transfusions. Another key offering is Adefovir dipivoxil tablets, formulated to combat Hepatitis B by inhibiting HBV DNA polymerase activity and disrupting the virus's DNA. Additionally, L-threonine is provided for its application in animal feed premixes, particularly for pigs and poultry. Star Lake Bioscience further supplies disodium 5'-ribonucleotide, utilized in the treatment of chronic hepatitis, muscular atrophy, and certain eye conditions. Similarly, disodium 5-inosinate addresses issues like leukopenia, thrombocytopenia, and both acute and chronic hepatitis. Inosine is another significant product, prescribed for various ailments including chronic hepatitis, heart disease, low white blood cell or platelet counts, and central choroidoretinitis. Furthermore, disodium 5'-guanylate finds application in food preservation, such as for canned meats, ham, and other salted meat products. The company's broad portfolio also features compounds such as ribavirin, adenosine, adenine, memantine hydrochloride, arginine, D-ribose, fructose syrup, L-valine, and L-lysine, among others. These diverse offerings are marketed under the proprietary brands Star Lake and Yue Bao.
Cena akcji
$0.63907023
Ostatnia synchronizacja: 2026-08-28
Kapitalizacja rynkowa
$1.06B
Zmiana (1 dzień)
1.15%
Zmiana (1 rok)
-44.43%
Kraj
CN
Handel Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (600866)

Kategoria

Cena 600866 z kapitalizacją rynkową B
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Star Lake Bioscience Co., Inc.Zhaoqing Guangdong
600866
$0.63907023
Kapitalizacja rynkowa Star Lake Bioscience Co., Inc.Zhaoqing Guangdong(600866)
Kapitalizacja rynkowa: $1.06B
Na dzień August 2026 spółka Star Lake Bioscience Co., Inc.Zhaoqing Guangdong ma kapitalizację rynkową wynoszącą $1.06B. Według naszych danych, czyni to Star Lake Bioscience Co., Inc.Zhaoqing Guangdong 9223rd najcenniejszą firmą na świecie pod względem kapitalizacji rynkowej. Kapitalizacja rynkowa to całkowita wartość rynkowa wszystkich wyemitowanych akcji spółki giełdowej i jest powszechnie stosowana do oceny jej wartości.
Historia kapitalizacji rynkowej Star Lake Bioscience Co., Inc.Zhaoqing Guangdong od 1994 do 2026
600866 w porównaniu do 5 najpopularniejszych stocks
Cena za 600866 Aktywa B Kapitalizacja rynkowa B Wyniki
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Star Lake Bioscience Co., Inc.Zhaoqing Guangdong
$3,168.19 $1.06B
$5.264T +495,650.52%
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Star Lake Bioscience Co., Inc.Zhaoqing Guangdong
$2,829.58 $1.06B
$4.701T +442,665.68%
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Star Lake Bioscience Co., Inc.Zhaoqing Guangdong
$2,514.14 $1.06B
$4.177T +393,306.17%
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Star Lake Bioscience Co., Inc.Zhaoqing Guangdong
$2,297.60 $1.06B
$3.817T +359,422.44%
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Star Lake Bioscience Co., Inc.Zhaoqing Guangdong
$1,725.18 $1.06B
$2.866T +269,851.31%